A Study of Evacetrapib in High-Risk Vascular Disease

NCT01687998 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12092

Enrollment

INDUSTRY

Sponsor class

Stopped Study termination due to insufficient efficacy.

Conditions

Cardiovascular Diseases

Interventions

DRUG: Evacetrapib
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]